Atlas Trials

Angiotensin II in Liver Transplantation

Clinical trial NCT04901169 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04901169
Sponsor
University of California, San Francisco
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Liver Transplant; ComplicationsVasoplegia
Start date
2022-06-28
Primary completion
2026-03-18
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.